ClinicalTrials.gg
RecruitingNCT06738784ECO2PSYUpdated Mar 16, 2026

Evaluation of the Efficiency of the PRPP (Perceive, Recall, Plan and Perform) Task Analysis System on Support and Orientation Decisions for People With Aging Psychiatric Disorders (PATPV) Living in Independent Housing.

An interventional study of Perceive, Recall, Plan and Perform (PRPP) evaluation in Mental Health, Aging Disorder and Psychiatric Disorder, sponsored by Centre Hospitalier Charles Perrens, Bordeaux. Recruiting at 1 site in France. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-03-16.

Primary conditionMental DisordersRegistry: Psychological Well-BeingReclassifiedWhy we changed it
Registry
Psychological Well-Being — the first condition term the registry derived for this study.
ClinicalTrials.gg
Mental Disorders
Why
  1. Psychological Well-Being is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Mental Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Centre Hospitalier Charles Perrens, Bordeaux · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Not applicable
Ages
40 Years to 65 Years
Sex
All
01

Study summary

Over the past 30 years, mental health policy has been geared towards increasing the number of people receiving care in the community, with a reduction of over 50% in the number of general psychiatric beds. The WHO recommends the implementation of alternatives to hospitalization, through the development of outpatient and home-based psychiatric care programs that support independent living.

People suffering from psychiatric disorders show cognitive decline as they age, including deficits in perception, attention, memory and problem-solving. These cognitive problems affect the ability to carry out the tasks of daily life, and make it more difficult to remain at home. In order to avoid hospitalization for these psychiatrically-stabilized patients who are losing their autonomy, it is necessary to take into account their mental and cognitive handicap, and to provide them with appropriate compensation.

Occupational therapy is a discipline concerned with the assessment, rehabilitation and integration of people with disabilities. Occupational therapists provide ecological assessments to support personalized care plans. The PRPP (Perceive, Recall, Plan and Perform) task analysis system is a validated, ecological tool that integrates an occupational therapy assessment and intervention model. The PRPP assessment measures occupational performance and the impact of cognitive impairments on information processing and on the cognitive strategies required to carry out activities. Research conducted in Canada illustrates the value of PRPP in supporting people with schizophrenia. To the best of our knowledge, no team has studied the use of PRPP in the decision-making process for maintaining people with aging psychiatric disorders (PATPV) at home.

Read the detailed description

The main hypothesis is that the use of the PRPP, through its scientific validity, will facilitate the decision-making of multi-professional care teams for the ambulatory support of PATPV to support :

  • maintenance of independent housing
  • or referral to a suitable place to live

This is a prospective, single-center study conducted within the "pathologies, handicap and aging" unit of the General and University Psychiatry (PGU) cluster at the Charles Perrens Hospital in Bordeaux.

The "pathologies, disability and aging" unit is dedicated to addressing the loss of autonomy and disability of people suffering from severe psychiatric disorders. One of its aims is to prevent hospitalization, particularly long-term hospitalization, for patients with chronic psychiatric pathologies who have become care-dependent. The program is structured around a multi-professional mobile team in charge of assessments, and a day hospital providing outpatient psychosocial rehabilitation care.

02

Conditions studied

  • Mental Health
  • Aging Disorder
  • Psychiatric Disorder

Browse trials for

Keywords

  • mental health
  • geriatric psychiatry
  • ergotherapy
03

In context

Mental Disorders Reclassified

1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.

This study's planned enrollment of 66 is below the median of 100 across 1,305 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Centre Hospitalier Charles Perrens, Bordeaux is the lead sponsor of 19 studies on the registry; 12 are open to participants now.

Compared within Mental Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Psychological Well-Being. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be at least 40 years old
  • Reside within the PGU sector (Mérignac, Pessac, Talence and Gradignan)
  • Receive support from the PGU - CHCP "pathologies, disability and aging" department.
  • Fluency in French

Exclusion criteria

Exclusion Criteria:

  • Being hospitalized for more than 18 months
  • Refuse inclusion in the research project
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    PRPP Evaluation

    T0 to T3 months: Evaluations * Multi-professional assessment by mobile team or day hospital * Completion of PRPP on 2 activities T3 months: First referral \- Decision on the participant's future orientation following the PRPP T3 months to T9 months: Outpatient psychosocial rehabilitation (standard care) * Personalized psychosocial rehabilitation program determined in part by the PRPP and carried out in the day hospital for all participants. * PRPP interventions (occupational therapy) T9 months: Reassessment and confirmation of orientation * Second round of PRPP based on activities assessed at T3 months * Questionnaires to help with referral decisions, completed by the multi-professional teams involved in the program, and by the treating psychiatrist after the second PRPP has been completed.

    Behavioral: Perceive, Recall, Plan and Perform (PRPP) evaluation

Interventions

  • BehavioralPerceive, Recall, Plan and Perform (PRPP) evaluation

    Passing the PRPP for 2 activities

06

What researchers measure

Primary outcomes

  1. Efficiency of the PRPP system for living orientation

    Scoring the PRPP system for monitoring changes in occupational performance following the implementation of a personalized psycho-social rehabilitation project.

    Time frame: 9 months after inclusion

Secondary outcomes

  1. Number of hospitalizations since inclusion

    Counting the number of hospitalizations

    Time frame: 12 months after inclusion

07

Study locations

1 of 1 sites recruiting
  • Centre Hospitalier Charles Perrens
    Bourdeaux, Gironde 33076, France
    Recruiting
08

References and documents

Publications

  • Chapparo, C., Ranka, J. L., & Nott, M. T. (2017). Perceive, Recall, Plan and Perform (PRPP) system of task analysis and intervention. In Occupational therapy for people experiencing illness, injury or impairment: Promoting occupation and participation (pp. 243-257). Elsevier
  • Aubin G, Chapparo C, Gelinas I, Stip E, Rainville C. Use of the Perceive, Recall, Plan and Perform System of Task Analysis for persons with schizophrenia: a preliminary study. Aust Occup Ther J. 2009 Jun;56(3):189-99. doi: 10.1111/j.1440-1630.2007.00725.x. PubMed 20854512 ↗
  • Aubin G, Stip E, Gelinas I, Rainville C, Chapparo C. Daily activities, cognition and community functioning in persons with schizophrenia. Schizophr Res. 2009 Feb;107(2-3):313-8. doi: 10.1016/j.schres.2008.08.002. Epub 2008 Sep 27. PubMed 18824328 ↗
  • Lindstad MO, Obstfelder AU, Sveen U, Stigen L. Feasibility of the Perceive, Recall, Plan and Perform system of intervention for persons with brain injury in community-based rehabilitation: a pilot for a multiple-baseline design study. BMJ Open. 2023 Jun 28;13(6):e067593. doi: 10.1136/bmjopen-2022-067593. PubMed 37380207 ↗
  • Lindstad MO, Obstfelder AU, Sveen U, Stigen L. Effectiveness of the Perceive, Recall, Plan and Perform intervention for persons with brain injury in community-based rehabilitation: protocol for a single-case experimental design with multiple baselines. BMJ Open. 2022 Oct 5;12(10):e060206. doi: 10.1136/bmjopen-2021-060206. PubMed 36198473 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Dec 2026, 24 months after the start.

Of 668 non-industry interventional studies with no phase under Mental Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 45. This study's planned 24 months is below that.

Counting every sponsor, half of 682 studies reached it within 29 months; a quarter within 13 and three quarters within 45.

Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2024
First posted
Dec 18, 2024
StartActual
Dec 9, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Mar 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06738784
Lead sponsor
Centre Hospitalier Charles Perrens, Bordeaux
Responsible party
Sponsor
First posted
Dec 18, 2024
Start date
Dec 9, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Mar 16, 2026

Study contacts

Julie BONVALLET
Contact
jbonvallet@ch-perrens.fr
05.33.57.80.23
Helen SAVARIEAU
Contact
hsavarieau@ch-perrens.fr
05.56.56.35.56

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion